355 related articles for article (PubMed ID: 19665949)
1. Analysis of endogenous ATP analogs and mevalonate pathway metabolites in cancer cell cultures using liquid chromatography-electrospray ionization mass spectrometry.
Jauhiainen M; Mönkkönen H; Räikkönen J; Mönkkönen J; Auriola S
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2967-75. PubMed ID: 19665949
[TBL] [Abstract][Full Text] [Related]
2. Mevalonate pathway intermediates downregulate zoledronic acid-induced isopentenyl pyrophosphate and ATP analog formation in human breast cancer cells.
Räikkönen J; Mönkkönen H; Auriola S; Mönkkönen J
Biochem Pharmacol; 2010 Mar; 79(5):777-83. PubMed ID: 19819230
[TBL] [Abstract][Full Text] [Related]
3. The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro.
Mitrofan LM; Pelkonen J; Mönkkönen J
Bone; 2009 Dec; 45(6):1153-60. PubMed ID: 19699819
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid-induced IPP/ApppI production in vivo.
Mönkkönen H; Ottewell PD; Kuokkanen J; Mönkkönen J; Auriola S; Holen I
Life Sci; 2007 Sep; 81(13):1066-70. PubMed ID: 17850825
[TBL] [Abstract][Full Text] [Related]
5. Zoledronic acid induces formation of a pro-apoptotic ATP analogue and isopentenyl pyrophosphate in osteoclasts in vivo and in MCF-7 cells in vitro.
Räikkönen J; Crockett JC; Rogers MJ; Mönkkönen H; Auriola S; Mönkkönen J
Br J Pharmacol; 2009 Jun; 157(3):427-35. PubMed ID: 19371349
[TBL] [Abstract][Full Text] [Related]
6. High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo.
Benzaïd I; Mönkkönen H; Stresing V; Bonnelye E; Green J; Mönkkönen J; Touraine JL; Clézardin P
Cancer Res; 2011 Jul; 71(13):4562-72. PubMed ID: 21646473
[TBL] [Abstract][Full Text] [Related]
7. In vivo phosphoantigen levels in bisphosphonate-treated human breast tumors trigger Vγ9Vδ2 T-cell antitumor cytotoxicity through ICAM-1 engagement.
Benzaïd I; Mönkkönen H; Bonnelye E; Mönkkönen J; Clézardin P
Clin Cancer Res; 2012 Nov; 18(22):6249-59. PubMed ID: 23032740
[TBL] [Abstract][Full Text] [Related]
8. Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells.
Räikkönen J; Taskinen M; Dunford JE; Mönkkönen H; Auriola S; Mönkkönen J
Biochem Biophys Res Commun; 2011 Apr; 407(4):663-7. PubMed ID: 21420384
[TBL] [Abstract][Full Text] [Related]
9. A new endogenous ATP analog (ApppI) inhibits the mitochondrial adenine nucleotide translocase (ANT) and is responsible for the apoptosis induced by nitrogen-containing bisphosphonates.
Mönkkönen H; Auriola S; Lehenkari P; Kellinsalmi M; Hassinen IE; Vepsäläinen J; Mönkkönen J
Br J Pharmacol; 2006 Feb; 147(4):437-45. PubMed ID: 16402039
[TBL] [Abstract][Full Text] [Related]
10. Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates.
van Beek E; Pieterman E; Cohen L; Löwik C; Papapoulos S
Biochem Biophys Res Commun; 1999 Oct; 264(1):108-11. PubMed ID: 10527849
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of a Biologically Important Adenosine Triphosphate Analogue, ApppD.
Turhanen PA
ACS Omega; 2017 Jun; 2(6):2835-2838. PubMed ID: 30023676
[TBL] [Abstract][Full Text] [Related]
12. Farnesol production from Escherichia coli by harnessing the exogenous mevalonate pathway.
Wang C; Yoon SH; Shah AA; Chung YR; Kim JY; Choi ES; Keasling JD; Kim SW
Biotechnol Bioeng; 2010 Oct; 107(3):421-9. PubMed ID: 20552672
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of ATP derivatives of compounds of the mevalonate pathway (isopentenyl di- and triphosphate; geranyl di- and triphosphate, farnesyl di- and triphosphate, and dimethylallyl diphosphate) catalyzed by T4 RNA ligase, T4 DNA ligase and other ligases Potential relationship with the effect of bisphosphonates on osteoclasts.
Sillero MA; de Diego A; Tavares JE; Silva JA; Pérez-Zúñiga FJ; Sillero A
Biochem Pharmacol; 2009 Aug; 78(4):335-43. PubMed ID: 19414000
[TBL] [Abstract][Full Text] [Related]
14. Specific requirements for Vgamma9Vdelta2 T cell stimulation by a natural adenylated phosphoantigen.
Vantourout P; Mookerjee-Basu J; Rolland C; Pont F; Martin H; Davrinche C; Martinez LO; Perret B; Collet X; Périgaud C; Peyrottes S; Champagne E
J Immunol; 2009 Sep; 183(6):3848-57. PubMed ID: 19710470
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of the mevalonate pathway by cholesterol depletion abolishes tolerance to N-bisphosphonate induced Vγ9Vδ2 T cell cytotoxicity in PC-3 prostate cancer cells.
Arkko S; Zlatev HP; Mönkkönen H; Räikkönen J; Benzaïd I; Clézardin P; Mönkkönen J; Määttä JA
Cancer Lett; 2015 Feb; 357(1):279-285. PubMed ID: 25444923
[TBL] [Abstract][Full Text] [Related]
16. Exploring the precursor ion exclusion feature of liquid chromatography-electrospray ionization quadrupole time-of-flight mass spectrometry for improving protein identification in shotgun proteome analysis.
Wang N; Li L
Anal Chem; 2008 Jun; 80(12):4696-710. PubMed ID: 18479145
[TBL] [Abstract][Full Text] [Related]
17. Bisphosphonate-induced ATP analog formation and its effect on inhibition of cancer cell growth.
Mönkkönen H; Kuokkanen J; Holen I; Evans A; Lefley DV; Jauhiainen M; Auriola S; Mönkkönen J
Anticancer Drugs; 2008 Apr; 19(4):391-9. PubMed ID: 18454049
[TBL] [Abstract][Full Text] [Related]
18. Probenecid as a sensitizer of bisphosphonate-mediated effects in breast cancer cells.
Ebert R; Meissner-Weigl J; Zeck S; Määttä J; Auriola S; Coimbra de Sousa S; Mentrup B; Graser S; Rachner TD; Hofbauer LC; Jakob F
Mol Cancer; 2014 Dec; 13():265. PubMed ID: 25496233
[TBL] [Abstract][Full Text] [Related]
19. Selective Calcium-Dependent Inhibition of ATP-Gated P2X3 Receptors by Bisphosphonate-Induced Endogenous ATP Analog ApppI.
Ishchenko Y; Shakirzyanova A; Giniatullina R; Skorinkin A; Bart G; Turhanen P; Määttä JA; Mönkkönen J; Giniatullin R
J Pharmacol Exp Ther; 2017 Jun; 361(3):472-481. PubMed ID: 28404687
[TBL] [Abstract][Full Text] [Related]
20. Quantitative determination of isopentenyl diphosphate in cultured mammalian cells.
Tong H; Kuder CH; Wasko BM; Hohl RJ
Anal Biochem; 2013 Feb; 433(1):36-42. PubMed ID: 23000003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
